title: Author reply: To PMID 23246118.
authors.affiliation: Qingdao, China.
authors.forename: Min
authors.initials: M
authors.lastname: Chen
authors.forename: Weiyun
authors.initials: W
authors.lastname: Shi
authors.forename: Xianggen
authors.initials: X
authors.lastname: Wu
authors.forename: Lixin
authors.initials: L
authors.lastname: Xie
mesh_terms: D001766:Blindness / Q000601:surgery*; D003316:Corneal Diseases / Q000150:complications*; D016572:Cyclosporine / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D004728:Endothelium, Corneal / Q000473:pathology*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D015948:Keratoplasty, Penetrating; D008297:Male
chemical_list: D016572:Cyclosporine